Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Adenosine A3 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Adenosine A1 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Adenosine A2a receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 288 aa | 20.8 % | |
Onchocerca volvulus | Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog | Adenosine A1 receptor | 326 aa | 286 aa | 22.7 % |
Schistosoma mansoni | dro/myosuppressin receptor | Adenosine A1 receptor | 326 aa | 326 aa | 22.1 % |
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 320 aa | 24.4 % | |
Schistosoma japonicum | Rhodopsin, putative | Adenosine A3 receptor | 320 aa | 320 aa | 23.8 % |
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 308 aa | 20.5 % | |
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 282 aa | 20.6 % | |
Echinococcus granulosus | thyrotropin releasing hormone receptor | Adenosine A2a receptor | 410 aa | 342 aa | 23.1 % |
Schistosoma mansoni | neuropeptide receptor | Adenosine A3 receptor | 320 aa | 306 aa | 23.5 % |
Onchocerca volvulus | Adenosine A2a receptor | 410 aa | 337 aa | 23.1 % | |
Echinococcus granulosus | neuropeptide receptor | Adenosine A3 receptor | 320 aa | 290 aa | 23.4 % |
Schistosoma japonicum | 5-hydroxytryptamine receptor 4, putative | Adenosine A3 receptor | 320 aa | 311 aa | 27.3 % |
Loa Loa (eye worm) | hypothetical protein | Adenosine A1 receptor | 326 aa | 300 aa | 24.3 % |
Schistosoma japonicum | Alpha-1A adrenergic receptor, putative | Adenosine A3 receptor | 320 aa | 325 aa | 24.9 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Adenosine A2a receptor | 410 aa | 366 aa | 25.4 % |
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 350 aa | 24.9 % | |
Schistosoma mansoni | peptide (allatostatin)-like receptor | Adenosine A3 receptor | 320 aa | 296 aa | 27.0 % |
Loa Loa (eye worm) | neuropeptide F receptor | Adenosine A3 receptor | 320 aa | 321 aa | 24.0 % |
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 295 aa | 23.4 % | |
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Adenosine A2a receptor | 410 aa | 352 aa | 23.6 % |
Schistosoma japonicum | ko:K04134 cholinergic receptor, invertebrate, putative | Adenosine A3 receptor | 320 aa | 332 aa | 24.4 % |
Echinococcus multilocularis | tachykinin peptides receptor 99D | Adenosine A3 receptor | 320 aa | 297 aa | 26.6 % |
Schistosoma mansoni | biogenic amine (5HT) receptor | Adenosine A2a receptor | 410 aa | 399 aa | 28.1 % |
Schistosoma mansoni | opsin-like receptor | Adenosine A3 receptor | 320 aa | 300 aa | 22.0 % |
Onchocerca volvulus | Adenosine A3 receptor | 320 aa | 311 aa | 23.5 % | |
Schistosoma japonicum | ko:K04135 adrenergic receptor, alpha 1a, putative | Adenosine A2a receptor | 410 aa | 346 aa | 28.3 % |
Echinococcus granulosus | allatostatin A receptor | Adenosine A2a receptor | 410 aa | 368 aa | 22.6 % |
Echinococcus multilocularis | thyrotropin releasing hormone receptor | Adenosine A2a receptor | 410 aa | 342 aa | 23.1 % |
Echinococcus granulosus | tachykinin peptides receptor 99D | Adenosine A3 receptor | 320 aa | 297 aa | 26.6 % |
Onchocerca volvulus | Mitochondrial inner membrane protein homolog | Adenosine A2a receptor | 410 aa | 340 aa | 27.9 % |
Onchocerca volvulus | Adenosine A2a receptor | 410 aa | 356 aa | 23.9 % | |
Echinococcus multilocularis | neuropeptide receptor | Adenosine A3 receptor | 320 aa | 282 aa | 24.1 % |
Echinococcus multilocularis | allatostatin A receptor | Adenosine A2a receptor | 410 aa | 372 aa | 22.8 % |
Schistosoma japonicum | ko:K04255 opsin 4 (melanopsin), putative | Adenosine A3 receptor | 320 aa | 370 aa | 21.4 % |
Schistosoma mansoni | adenoreceptor | Adenosine A3 receptor | 320 aa | 319 aa | 27.9 % |
Schistosoma mansoni | opsin-like receptor | Adenosine A3 receptor | 320 aa | 307 aa | 26.4 % |
Schistosoma mansoni | neuropeptide receptor | Adenosine A3 receptor | 320 aa | 286 aa | 21.3 % |
Brugia malayi | hypothetical protein | Adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Loa Loa (eye worm) | hypothetical protein | Adenosine A3 receptor | 320 aa | 309 aa | 24.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0774 | 0.1329 | 0.2284 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0492 | 0.0311 | 0.2342 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0646 | 0.0867 | 0.6526 |
Loa Loa (eye worm) | hypothetical protein | 0.0415 | 0.003 | 0.0229 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.1246 | 0.3031 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.3176 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0539 | 0.0479 | 0.3608 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.1246 | 0.3031 | 0.268 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0646 | 0.0867 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0646 | 0.0867 | 0.152 |
Entamoeba histolytica | hypothetical protein | 0.0539 | 0.0479 | 0.3025 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0539 | 0.0479 | 0.1497 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0646 | 0.0867 | 0.6526 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0646 | 0.0867 | 0.2789 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0646 | 0.0867 | 0.0407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0646 | 0.0867 | 0.6526 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0646 | 0.0867 | 0.6526 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0646 | 0.0867 | 1 |
Leishmania major | hypothetical protein, conserved | 0.1206 | 0.2888 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0646 | 0.0867 | 0.2789 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.1246 | 0.3031 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0646 | 0.0867 | 0.2789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0539 | 0.0479 | 0.3608 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Giardia lamblia | GTOR | 0.0646 | 0.0867 | 0.5 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.1246 | 0.3031 | 0.268 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1082 | 0.2439 | 0.8027 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0774 | 0.1329 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0774 | 0.1329 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0646 | 0.0867 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.1246 | 0.3031 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0774 | 0.1329 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.1246 | 0.3031 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0646 | 0.0867 | 0.152 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0646 | 0.0867 | 0.0407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Toxoplasma gondii | FATC domain-containing protein | 0.0539 | 0.0479 | 0.5528 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0646 | 0.0867 | 0.6526 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0.108 % | Binding affinity towards adenosine A3 receptor by measuring its ability to displace [125I]-AB-MECA binding to membranes prepared from HEK-293 cells | ChEMBL. | 9703464 |
Inhibition (binding) | = 0.108 % | Binding affinity towards adenosine A3 receptor by measuring its ability to displace [125I]-AB-MECA binding to membranes prepared from HEK-293 cells | ChEMBL. | 9703464 |
Inhibition (binding) | = 4.77 % | Binding affinity towards adenosine A2A receptor by measuring its ability to displace [3H]-CGS- 21680 in rat striatal membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | = 4.77 % | Binding affinity towards adenosine A2A receptor by measuring its ability to displace [3H]-CGS- 21680 in rat striatal membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | = 5.93 % | Binding affinity towards adenosine A1 receptor by measuring its ability to displace [3H]-R-PIA in rat brain membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | = 5.93 % | Binding affinity towards adenosine A1 receptor by measuring its ability to displace [3H]-R-PIA in rat brain membranes at a concentration of 10e-4 M | ChEMBL. | 9703464 |
Inhibition (binding) | < 10 % | Inhibition of [3H]-isradipine binding to L-type [Ca2+] channel of rat brain membranes | ChEMBL. | 8709132 |
Inhibition (binding) | < 10 % | Inhibition of [3H]-isradipine binding to L-type [Ca2+] channel of rat brain membranes | ChEMBL. | 8709132 |
Ki (binding) | = 0.108 uM | Displacement of specific [125I]-AB-MECA binding at human adenosine A3 receptor. | ChEMBL. | 9258367 |
Ki (binding) | = 0.108 uM | Inhibition of [125I]- AB-MECA binding to human Adenosine A3 recptors expressed in HEK cells | ChEMBL. | 8917655 |
Ki (binding) | = 0.108 uM | Displacement of [125]AB-MECA binding to human Adenosine A3 receptor expressed in HEK cells | ChEMBL. | 8709132 |
Ki (binding) | = 0.108 uM | Displacement of specific [125I]-AB-MECA binding at human adenosine A3 receptor. | ChEMBL. | 9258367 |
Ki (binding) | = 0.108 uM | Inhibition of [125I]- AB-MECA binding to human Adenosine A3 recptors expressed in HEK cells | ChEMBL. | 8917655 |
Ki (binding) | = 0.108 uM | Displacement of [125]AB-MECA binding to human Adenosine A3 receptor expressed in HEK cells | ChEMBL. | 8709132 |
Ki (binding) | = 0.11 uM | Displacement of [125 I]AB-MECA from Adenosine A3 receptor expressed in HEK cells | ChEMBL. | 10447949 |
Ki (binding) | = 0.11 uM | Displacement of [125 I]AB-MECA from Adenosine A3 receptor expressed in HEK cells | ChEMBL. | 10447949 |
Ki (binding) | = 4.16 uM | Binding affinity against rat Adenosine A3 receptor from CHO cells | ChEMBL. | 8709132 |
Ki (binding) | = 4.16 uM | Binding affinity against rat Adenosine A3 receptor from CHO cells | ChEMBL. | 8709132 |
Ki (binding) | = 4.77 uM | Displacement of specific [3H]-CGS- 21680 binding at Adenosine A2A receptor in rat striatal membranes. | ChEMBL. | 9258367 |
Ki (binding) | = 4.77 uM | Displacement of [3H]-CGS- 21680 from Adenosine A2A receptor of rat striatal membrane | ChEMBL. | 8917655 |
Ki (binding) | = 4.77 uM | Displacement of [3H]-CGS-21,680 from Adenosine A2A receptor of rat striatal membrane at 10e-4 microM | ChEMBL. | 10447949 |
Ki (binding) | = 4.77 uM | Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes | ChEMBL. | 8709132 |
Ki (binding) | = 4.77 uM | Displacement of specific [3H]-CGS- 21680 binding at Adenosine A2A receptor in rat striatal membranes. | ChEMBL. | 9258367 |
Ki (binding) | = 4.77 uM | Displacement of [3H]-CGS- 21680 from Adenosine A2A receptor of rat striatal membrane | ChEMBL. | 8917655 |
Ki (binding) | = 4.77 uM | Displacement of [3H]-CGS-21,680 from Adenosine A2A receptor of rat striatal membrane at 10e-4 microM | ChEMBL. | 10447949 |
Ki (binding) | = 4.77 uM | Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes | ChEMBL. | 8709132 |
Ki (binding) | = 5.93 uM | Displacement of specific [3H]-(R)-PIA binding at adenosine A1 receptor from rat brain membranes. | ChEMBL. | 9258367 |
Ki (binding) | = 5.93 uM | Binding affinity against adenosine A1 receptor in rat cerebral cortex membrane by radioligand binding assay using [3H]-(R)-PIA. | ChEMBL. | 8917655 |
Ki (binding) | = 5.93 uM | Displacement of [3H]-R-PIA from adenosine A1 receptor of rat brain membrane | ChEMBL. | 10447949 |
Ki (binding) | = 5.93 uM | Displacement of [3H]-(R)-PIA binding to Adenosine A1 receptor in rat brain membranes | ChEMBL. | 8709132 |
Ki (binding) | = 5.93 uM | Displacement of specific [3H]-(R)-PIA binding at adenosine A1 receptor from rat brain membranes. | ChEMBL. | 9258367 |
Ki (binding) | = 5.93 uM | Binding affinity against adenosine A1 receptor in rat cerebral cortex membrane by radioligand binding assay using [3H]-(R)-PIA. | ChEMBL. | 8917655 |
Ki (binding) | = 5.93 uM | Displacement of [3H]-R-PIA from adenosine A1 receptor of rat brain membrane | ChEMBL. | 10447949 |
Ki (binding) | = 5.93 uM | Displacement of [3H]-(R)-PIA binding to Adenosine A1 receptor in rat brain membranes | ChEMBL. | 8709132 |
Ratio (binding) | = 1.15 | Selectivity ratio of Ki for rat A2A and A3 adenosine receptors | ChEMBL. | 8709132 |
Ratio (binding) | = 1.43 | Selectivity ratio of Ki for rat A1 and A3 adenosine receptor | ChEMBL. | 8709132 |
Ratio (binding) | = 38.6 | Selectivity ratio of Ki for rat A3 and human A3 adenosine receptors | ChEMBL. | 8709132 |
Ratio (binding) | = 55 | Selectivity for binding affinity towards A1 adenosine receptor in rat brain membrane and human A3 receptor expressed in HEK cells | ChEMBL. | 9703464 |
Selectivity ratio (functional) | = 55 | Selectivity ratio measured as the Ki value of rat A1 receptor to that of hA3 receptor. | ChEMBL. | 9258367 |
Selectivity ratio (binding) | = 55 | Relative affinities for rat adenosine A1 and human adenosine A3 receptors | ChEMBL. | 8917655 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
5 literature references were collected for this gene.